APW
XERS icon

Atlantic Private Wealth’s Xeris Biopharma Holdings XERS Stock Holding History

Atlantic Private Wealth’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238 Hold
30
– – ﹤0.01% 296
2026
Q1 		$174 Hold
30
– – ﹤0.01% 311
2025
Q4 		$236 Buy
+30
New +$236 ﹤0.01% 380

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Atlantic Private Wealth's XERS Position: Q2 2026 in Review

Atlantic Private Wealth held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 30 shares worth $238. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Atlantic Private Wealth first reported a position in XERS in Q4 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Atlantic Private Wealth held 30 shares of Xeris Biopharma Holdings worth $238 as of Q2 2026.
  • Atlantic Private Wealth left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q2 2026, its #296 holding.
  • Atlantic Private Wealth first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.